Skip to main content
. 2022 Mar 3;9:811176. doi: 10.3389/fmed.2022.811176

Figure 3.

Figure 3

Possible models of SARS-CoV-2 infection, interactions between the human gut and lungs, and potential positive immune responses triggered by probiotics and other prebiotics against lung infection and injury (69, 70, 7880).